News

At the annual meeting of the German Society of Cardiology (DGK), four scientists will be honoured with the new DGK AFNET Young Investigator Award, sponsored by the Atrial Fibrillation Competence Network (AFNET), for current research work on atrial fibrillation. The presentations of the award winners and the award ceremony will take place on Friday 05.04.2024 in Mannheim.

‘This new prize has been established to mark the 20th anniversary of AFNET. It is intended to recognise outstanding results by young researchers working on atrial fibrillation. With this prize, AFNET wants to encourage the next generation to focus on better understanding, more accurate diagnosis and more successful treatment of atrial fibrillation,’ says Paulus Kirchhof, Chairman of the Board of AFNET.

We are pleased to present you our bookelt on the occasion of our 20th anniversary.

You can read/download it here.

ANET associated events: 

25 August 2023, 8:30, “Stockholm”, Stroke and bleeding risk in atrial fibrillation: walking the tight rope (Paulus Kirchhof)

More information.

25 August 2023, 11:15, “Amsterdam”, Hot Line Session:  NOAH-AFNET 6: Oral anticoagulation in patients with atrial high rate episodes (Paulus Kirchhof)

More information.

25. August 2023, 16:30, “Hub Rembrandt”, Ask the Trialist from Hot Line 1:  NOAH-AFNET 6 (Paulus Kirchhof)

The results of the AXADIA-AFNET8 trial and another EAST-AFNET4 subanalysis will be presented at this year’s AHA congress (Chicago, US) :

Featured Science Session (FS.03): Featured Science in Heart Rhythm Medicine
Apixaban or vitamin K antagonists for stroke prevention in patients with atrial fibrillation on hemodialysis: Results of the randomized AXADIA-AFNET 8 trial
Monday, 7th of November 2022 | 0:20 – 0:30 (CET) / Sunday, 6th of November 2022 | 5:20pm – 5:30pm (CST)
Speaker: Dr. Paulus Kirchhof
More information

Session 0880 – Plenary 01: Opening, Presentation of Award and Late Breaking Trials (ID 294) Early rhythm-control therapy for atrial fibrillation in patients with history of stroke in the EAST-AFNET4 trial
Wednesday, 26th of October 2022 | / 12:10 – 12:20 pm (CEST)/ 18:10 – 18:20 pm (SGT), room “Hall 406”
Speaker: Märit Jensen

The study “CABA-HFPEF-DZHK27” (CAtheter-Based Ablation of atrial fibrillation vs. conventional treatment in patients with Heart Failure with Preserved Ejection Fraction) is aiming for a better therapy for patients with heart failure and atrial fibrillation. Charité (Berlin, Germany) has the overall responsibility for the study. This trial is supported by German Centre for Cardiovascular Research (DZHK). Further information can be found in the press release (german only). 

Posts NEWS Mon, 08.08.2022 8th AFNET/EHRA Consensus Conference 2021 Paper published The 8th AFNET/EHRA Consensus Conference Paper 2021 “Early diagnosis and better rhythm management to improve outcomes in patients with atrial fibrillation” has been published: https://academic.oup.com/europace/advance-article/doi/10.1093/europace/euac062/6650662  

Posts NEWS Wen, 13.07.2022 Theme booklet of neurology The current issue of “theme booklet of neurology” reports on Atrial Fibrillation NETwork (AFNET), get your access here (german only).

Posts NEWS Thu, 07.07.2022 EAST-AFNET 4 @ ESC 2022 The newest subanalysis of the EAST-AFNET 4 study will be presented at this year’s ESC congress 2022 in Barcelona: Latest science in atrial fibrillationPredictors and mediators of improved outcomes on early rhythm control an analysis of the EAST AFNET – 4 data set.Monday, 29th of August … Read more

The design paper was successfully published in “Frontiers in cardiovascular medicine”. Get access to the paper here.